These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 31627092)
1. Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/β-catenin signaling and is regulated by miR-133a-3p. Zhou Y; Jin Z; Wang C Biomed Pharmacother; 2019 Dec; 120():109449. PubMed ID: 31627092 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p. Yang H; Qi Y; Wang XL; Gu JJ; Shi TM Mol Cell Biochem; 2020 Apr; 467(1-2):95-105. PubMed ID: 32095930 [TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway. Zhang Y; Dun Y; Zhou S; Huang XH Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819 [TBL] [Abstract][Full Text] [Related]
4. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway. Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084 [TBL] [Abstract][Full Text] [Related]
5. The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p. Wang L; Ren C; Xu Y; Yang L; Chen Y; Zhu Y J Ovarian Res; 2021 Jun; 14(1):77. PubMed ID: 34116704 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways. Zhang R; Shi H; Ren F; Feng W; Cao Y; Li G; Liu Z; Ji P; Zhang M J Exp Clin Cancer Res; 2019 Dec; 38(1):494. PubMed ID: 31842953 [TBL] [Abstract][Full Text] [Related]
7. Angelica sinensis polysaccharide suppresses the Wnt/β-catenin-mediated malignant biological behaviors of breast cancer cells via the miR-3187-3p/PCDH10 axis. Cai Y; Wang Y; Su W; Zhou X; Lu C Biochem Pharmacol; 2024 Jul; 225():116295. PubMed ID: 38762145 [TBL] [Abstract][Full Text] [Related]
8. PYGB Promoted Tumor Progression by Regulating Wnt/β-Catenin Pathway in Gastric Cancer. Xia B; Zhang K; Liu C Technol Cancer Res Treat; 2020; 19():1533033820926592. PubMed ID: 32462986 [TBL] [Abstract][Full Text] [Related]
9. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway. Huang M; Liao X; Li L; Li G; Chen M Tissue Cell; 2021 Dec; 73():101672. PubMed ID: 34736163 [TBL] [Abstract][Full Text] [Related]
10. Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis. Cui G; Wang H; Liu W; Xing J; Song W; Zeng Z; Liu L; Wang H; Wang X; Luo H; Leng X; Shen S Front Cell Dev Biol; 2020; 8():566494. PubMed ID: 33324633 [TBL] [Abstract][Full Text] [Related]
11. miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression. Liu L; Ning Y; Yi J; Yuan J; Fang W; Lin Z; Zeng Z Biomed Pharmacother; 2020 May; 125():109865. PubMed ID: 32058212 [TBL] [Abstract][Full Text] [Related]
12. Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation. Hu S; Chang J; Ruan H; Zhi W; Wang X; Zhao F; Ma X; Sun X; Liang Q; Xu H; Wang Y; Yang Y Int J Biol Sci; 2021; 17(10):2504-2522. PubMed ID: 34326690 [No Abstract] [Full Text] [Related]
13. MiR-3682-3p promotes esophageal cancer progression by targeting FHL1 and activating the Wnt/β-catenin signaling pathway. Cai Y; Xia L; Zhu H; Cheng H; Tian Y; Sun L; Wang J; Lu N; Wang J; Chen Y Cell Signal; 2024 Jul; 119():111155. PubMed ID: 38565413 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway. Xiong L; Tang Y; Tang J; Liu Z; Wang X Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357 [No Abstract] [Full Text] [Related]
15. miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation. Salem M; Shan Y; Bernaudo S; Peng C Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013711 [TBL] [Abstract][Full Text] [Related]
16. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway. Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312 [TBL] [Abstract][Full Text] [Related]
17. microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway. Liang K; Liao L; Liu Q; Ouyang Q; Jia L; Wu G Clin Transl Oncol; 2021 Nov; 23(11):2350-2357. PubMed ID: 34133001 [TBL] [Abstract][Full Text] [Related]
18. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p. Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012 [TBL] [Abstract][Full Text] [Related]
19. Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing/inhibited Wnt/β-catenin signaling pathway activation. Liu HR; Zhao J Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):94-107. PubMed ID: 33506897 [TBL] [Abstract][Full Text] [Related]
20. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway. Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]